Research Article
A Fortified Method to Screen and Detect Left Ventricular Hypertrophy in Asymptomatic Hypertensive Adults: A Korean Retrospective, Cross-Sectional Study
Table 1
Baseline characteristics of study subjects according to the presence or absence of echocardiographic left ventricular hypertrophy by LV mass.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BMI, body mass index; BSA, body surface area; BUN, blood urea nitrogen; CD, cardiac diameter; Cr, serum creatinine; CTR, cardiothoracic ratio; CVA, Cornell voltage amplitude; DBP, diastolic blood pressure; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; IVSd, interventricular septum end-diastolic thickness; LV, left ventricle; LVEF, left ventricular ejection fraction; LVH, left ventricular hypertrophy; LVIDd, left ventricular end-diastolic diameter; LVIDs, left ventricular end-systolic diameter; LVPWd, left ventricular end-diastolic posterior wall thickness; LDL, low-density lipoprotein; SBP, systolic blood pressure; SLVA, Sokolow-Lyon voltage amplitude <0.05 <0.01. |